// App-Quantinova.ai

THU0094 : IN ACPA POSITIVE AT-RISK INDIVIDUALS WITHOUT CLINICAL ARTHRITIS, IS ULTRASOUND SUFFICIENTLY ACCURATE TO PREDICT PROGRESSION TO INFLAMMATORY ARTHRITIS?

Researchers

Presenter

  • L. Duquenne

Principal Investigators

  • K. Mankia

  • A. DI Matteo

  • L. Garcia-Montoya

  • J. Nam

  • P. Emery

Medical Centers

  • University of Leeds, Leeds Institue of Rheumatic and Musculoskeletal Medicine, Leeds, United Kingdom

  • Oxford NIHR Musculoskeletal Biomedical Research Unit, Oxford, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Inflammatory Arthritis

Biomarkers

  • C reactive protein

  • Major histocompatibility complex, class II, DR beta 1

Drug/Treatment

  • Orphenadrine Citrate

Outcome

  • N/A

Study Design

  • Prospective

  • Cohort

  • Single Center

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved